← All trials
NCT05621083
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2022
- Primary completion
- Jun 30, 2024
- Completion date
- Dec 31, 2026
- First posted
- Nov 17, 2022
- Last posted
- Nov 17, 2022
- Enrollment
- 52
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of OsloLead sponsor
- GC Rieber VivoMega ASCollaborator
- European CommissionCollaborator
- University of OsloReponsible party - principal investigator
- University of OsloSponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.